Navigation Links
Pharmasset Presents R7128 14-Day Monotherapy Study Results for the Treatment of Chronic Hepatitis C
Date:11/2/2007

in the placebo group than in the treated arms of this study. Safety is an important aspect of new HCV therapies, because the current standard of care is not always as well tolerated as desired."

The R7128 scientific presentation will be available for download in PDF format following the conference in the "R7128 Presentations & Publications" section of Pharmasset's website at http://www.pharmasset.com/pipeline/R7128-publications.asp.

R7128 Phase 1 Multiple Ascending Dose Study Overview

The Phase 1 clinical trial is a multiple center, observer-blinded, randomized and placebo-controlled study was conducted in 40 patients chronically-infected with HCV genotype 1 who previously failed interferon therapy. The primary objective was to assess the safety, tolerability and pharmacokinetics of R7128 after once-daily (QD) or twice-daily (BID) dosing for 14 days. The secondary objective was to assess antiviral activity by measuring the change in HCV RNA.

R7128 Safety Summary

R7128 was generally safe and well tolerated, and all patients completed the study. There were no serious adverse events, no adverse events requiring dose modification, no dose-related gastrointestinal adverse events and no clinically significant changes in hematologic or other laboratory parameters. The preliminary data on adverse events (AEs) reported shows the highest incidence of AEs was in the placebo group with 34 events in 7 of 8 patients receiving placebo. During treatment in patients receiving R7128, most of the AEs reported were of mild intensity. Eighteen AEs were reported in 7 of 8 subjects that received 750mg QD, 6 AEs in 3 of 8 subjects receiving 1500mg QD, 13 AEs in 4 of 8 subjects receiving 750mg BID and 14 AEs in 4 of 8 subjects receiving 1500mg BID. The most frequently reported AEs for patients receiving R7128 were headache (13), dry mouth (3), nausea (2), fatigue (2), tiredne
'/>"/>

SOURCE Pharmasset, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Ovarian Cancer Presents ‘Target Symptoms’ Six Months Before Diagnosi
2. IDM Pharma Presents Preliminary Results of Melanoma Vaccine Clinical Trial
3. Living Liver Donor Who Saved Life of Mother-in-law Represents Cedars-Sinai in Rose Parade
4. Childrens Hospital Boston Presents at the Society for Adolescent Medicine Annual Meeting
5. Monogram Presents Results of First ETag Breast Cancer Studies
6. Novagali Pharma Presents Phase III Clinical Trial of Vekacia(R) for Vernal Keratoconjunctivitis
7. Novel Actemra monotherapy in treating patients with early aggressive rheumatoid arthritis
8. Combination Therapy More Effective Than Monotherapy for Treating Migraine
9. Rural Canadians travel far for specialists: study
10. A new study surpasses Gene Therapy Hurdle
11. Tomato Sauce reduces Cancer Risk- Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... 26, 2015 Let’s not lose focus ... produce are today’s traffic magnets. Three out of 4 ... of their produce department, according to a Packaged Facts ... people are looking to add more fruits and vegetables ... Manager® Day is April 2. As featured in the ...
(Date:3/26/2015)... 2015 The American College of Traditional Chinese ... topics of the DAOM Program as well as Marketing Basics ... will be hosted by Dr. Carla Wilson, who will give ... on how to prepare for the spring quarter. The webinar ... 27, April 1 and April 3. Attendees can log in ...
(Date:3/26/2015)... MALVERN, PA (PRWEB) March 26, 2015 ... leading providers of continuing medical education, the ... for Culinary Medicine at Tulane University are ... in Culinary Medicine. The interdisciplinary program ... Specialist (CCMS) credential, is designed for physicians, nurse ...
(Date:3/26/2015)... U.S. medical real estate sales transactions ... to an exclusive new report now available only ... (HRE) data firm also announced that it has ... Partners: Harrison Street Real Estate Capital and Zeustra ... going strong, yields compressed, prices per square foot ...
(Date:3/26/2015)... 2015 BioPlus Specialty Pharmacy ... specialty pharmacies, announces the promotion of Sharon Ferrer ... of Pharmaceutical Relations. In this position, Ferrer will ... pharmaceuticals partners and providing key leadership in building ... expansion. , “Over the past seven years ...
Breaking Medicine News(10 mins):Health News:ACTCM Announces Upcoming Webinars 2Health News:Certified Culinary Medicine Specialist Program Jointly Launched by Goldring Center for Culinary Medicine at Tulane University and Cardiometabolic Risk Summit 2Health News:Certified Culinary Medicine Specialist Program Jointly Launched by Goldring Center for Culinary Medicine at Tulane University and Cardiometabolic Risk Summit 3Health News:Medical Real Estate Sales Topped $11.3 Billion in 2014 2Health News:Medical Real Estate Sales Topped $11.3 Billion in 2014 3Health News:Medical Real Estate Sales Topped $11.3 Billion in 2014 4Health News:BioPlus Specialty Pharmacy Expands Executive Team with New Position, Naming Sharon Ferrer as Vice President of Pharmaceutical Relations 2
... begun work into improving the lives of thousands of Cystic ... US-Ireland Research and Development Partnership grant. , The grant ... in the USA with funding for the Queen,s component provided ... Public Health Agency), Northern Ireland and the Medical Research Council. ...
... , THURSDAY, Feb. 3 (HealthDay News) -- A special ... disorder (ADHD) in young children, a new study suggests. ... 8 were placed on a diet containing no processed ... percent of them. And, when suspected trouble foods were ...
... bone marrow to become embryonic-like stem cells, a team ... the onset of the blood cancer leukemia in the ... blood cells obtained from a patient with leukemia," says ... directed a study aimed at generating all-purpose stem cells ...
... -- A single dose of the H1N1 swine flu vaccine ... study found. In order to assess the effectiveness of ... -- Canadian researchers looked at 552 patients with flu-like illness ... Dec. 5, 2009. Pandemic H1N1 was detected in 209 ...
... News) -- If you tend to overindulge in food and ... things you can do to ease the ill effects you ... Dr. Cynthia Yoshida offers the following suggestions: Stay ... Caffeine-free, non-carbonated drinks, such as water, can help lessen the ...
... (HealthDay News) -- The average starting salary for a female ... a huge increase from the $3,600 gap in 1999, finds ... difference isn,t known because it isn,t explained by gender differences ... researchers said. The study authors analyzed survey data from ...
Cached Medicine News:Health News:$2.8 million grant boosts cystic fibrosis research at Queen's 2Health News:Restrictive Diet May Reduce ADHD Symptoms 2Health News:Restrictive Diet May Reduce ADHD Symptoms 3Health News:Restrictive Diet May Reduce ADHD Symptoms 4Health News:New induced stem cells may unmask cancer at earliest stage 2Health News:Gender Gap in Starting Doctor Pay Grows 2
(Date:3/26/2015)... , 26. März 2015  Die ... wird vom 1. April 2015 an Zulassungsanträge für ... abgebenden Apotheken annehmen. Seit dem Start des ... Verband über 275 .pharmacy-Domainnamen zugelassen, die für ... Zeiten beantragt wurden. Die NABP startete .pharmacy ...
(Date:3/26/2015)... Mass. , March 26, 2015 /PRNewswire/ ... announced that it will present preclinical and ... at the 2015 American Association for Cancer ... 18-22, 2015 at the Pennsylvania Convention Center in Philadelphia. The presentations ... engineering and nanoliposomal technology platforms, as well ...
(Date:3/26/2015)... -- Gelesis , a clinical stage biotechnology ... to induce weight loss and improve glycemic control, ... of shares of convertible preferred stock for gross ... of approximately $4 million of outstanding convertible promissory ... to support the continued clinical development of its ...
Breaking Medicine Technology:Alle abgebenden Apotheken berechtigt, um ab dem 1. April 2015 .Pharmacy-Domainnamen zu beantragen 2Merrimack to Highlight Extensive Oncology Pipeline at the 2015 American Association for Cancer Research Annual Meeting 2Merrimack to Highlight Extensive Oncology Pipeline at the 2015 American Association for Cancer Research Annual Meeting 3Gelesis Closes $22M Equity Financing 2Gelesis Closes $22M Equity Financing 3
... NEW YORK, March 29, 2011 Reportlinker.com announces that ... catalogue: Point of Care Diagnostic Testing ... Point of care testing (POCT) enables rapid ... at the point of care facility where results can ...
... Questcor Pharmaceuticals, Inc. (Nasdaq:  QCOR) announced today that executive management ... April 5-6, 2011 at the New York Palace Hotel in ... Officer, is scheduled to present an overview of the Company ... To listen to the audio web cast of the ...
Cached Medicine Technology:Reportlinker Adds Point of Care Diagnostic Testing World Markets 2Reportlinker Adds Point of Care Diagnostic Testing World Markets 3Reportlinker Adds Point of Care Diagnostic Testing World Markets 4Reportlinker Adds Point of Care Diagnostic Testing World Markets 5Reportlinker Adds Point of Care Diagnostic Testing World Markets 6Reportlinker Adds Point of Care Diagnostic Testing World Markets 7Reportlinker Adds Point of Care Diagnostic Testing World Markets 8Reportlinker Adds Point of Care Diagnostic Testing World Markets 9Reportlinker Adds Point of Care Diagnostic Testing World Markets 10Reportlinker Adds Point of Care Diagnostic Testing World Markets 11Reportlinker Adds Point of Care Diagnostic Testing World Markets 12Reportlinker Adds Point of Care Diagnostic Testing World Markets 13Reportlinker Adds Point of Care Diagnostic Testing World Markets 14Reportlinker Adds Point of Care Diagnostic Testing World Markets 15Reportlinker Adds Point of Care Diagnostic Testing World Markets 16Reportlinker Adds Point of Care Diagnostic Testing World Markets 17Reportlinker Adds Point of Care Diagnostic Testing World Markets 18Reportlinker Adds Point of Care Diagnostic Testing World Markets 19
... STAT analyzer and data management ... to meet the traditional needs of data ... functions for the management of STAT analyzer ... and simple connectivity solution for both STAT ...
... syngo Dynamics network is a ... archiving system using evidence-based reporting ... clinical procedures. It has made ... reality for hospital echocardiography and ...
... dTC is a versatile solution designed to ... from preparation to diagnosis and therapy, ... AXIOM Artis dTC, your cath lab becomes ... that leaves you free to concentrate on ...
... cardiovascular system PLUS ... high-performance transesophageal cardiovascular imaging system ... phased array echocardiography system that ... images, even on your most ...
Medicine Products: